Abstract: To provide a light-emitting element with an improved reliability, a light-emitting element with a high current efficiency (or a high quantum efficiency), and a novel dibenzo[f,h]quinoxaline derivative that is favorably used in a light-emitting element which is one embodiment of the present invention. A light-emitting element includes an EL layer between an anode and a cathode. The EL layer includes a light-emitting layer; the light-emitting layer contains a first organic compound having an electron-transport property and a hole-transport property, a second organic compound having a hole-transport property, and a light-emitting substance; the combination of the first organic compound and the second organic compound forms an exciplex; the HOMO level of the first organic compound is lower than the HOMO level of the second organic compound; and a difference between the HOMO level of the first organic compound and the HOMO level of the second organic compound is less than or equal to 0.4 eV.

Abstract: There is provided an acoustically treated landing gear door for reducing noise from a landing gear of an aircraft. The acoustically treated landing gear door includes a landing gear door for attachment to the aircraft. The landing gear door includes an acoustic treatment assembly integrated on an inner mold line of an interior side, and extending within an interior cavity of the landing gear door. The acoustic treatment assembly includes a core structure having a first side and a second side, a plurality of core cells extending between the first side and the second side, and a drainage system. The acoustic treatment assembly further includes an acoustic facesheet and a nonporous backsheet. The acoustically treated landing gear door reduces the noise from the landing gear, when the landing gear is in a deployed position, by attenuating acoustic waves emanating from the landing gear and reflected off the acoustic treatment assembly.

Abstract: The present specification discloses a method for detecting an aneuploid of a Brassica oleracea plant, including: performing real-time PCR using DNA extracted from a sample derived from a Brassica oleracea plant to be tested as a template and DNA markers specific to each of two or more chromosomes of Brassica oleracea plant; and detecting chromosomal aneuploidy from a relative difference in amplification amount between the obtained DNA markers. According to one embodiment of the present invention, it is possible to simply, accurately, and rapidly detect an off-type (chromosomal aneuploid) that may occur in Brassica oleracea varieties, in a laboratory equipped with a general molecular biological equipment in the course of seed quality control and breeding research.

Abstract: Disclosed is a cytoplasmic male sterile plant of the genus Petunia having, in the mitochondrial genome thereof, a DNA molecule originated from the mitochondrial genome of a tobacco plant, or a hybrid plant with the cytoplasmic male sterile plant of the genus Petunia, or a progeny of the cytoplasmic male sterile plant of the genus Petunia or the hybrid plant. The cytoplasmic male sterile plant of the genus Petunia is a stable line in which the growth ability of young seedlings is improved and which is not susceptible to fertility restoration, and further, achieves diversification of available CMS cytoplasms.

Abstract: A single-stranded antisense oligonucleotide, or a pharmaceutically acceptable salt thereof, capable of modulating expression and/or function of RPS25 gene, wherein nucleotides of the single-stranded antisense oligonucleotide are bonded to each other via a phosphate group and/or a modified phosphate group, the single-stranded antisense oligonucleotide includes a gap region, a 3? wing region bonded to a 3? end of the gap region, and a 5? wing region bonded to a 5? end of the gap region, the gap region is a deoxyribose-based nucleic acid optionally including a nucleic acid having a modified sugar moiety, each of the 3? wing region and the 5? wing region is a modified nucleotide, the single-stranded antisense oligonucleotide has a base length of 12- to 30-mer, and a base sequence of the antisense oligonucleotide is: a base sequence with a sequence identity of 90% to 100% to a base sequence complementary to at least one target region of the same base length as the antisense oligonucleotide present in the base sequ

Abstract: Disclosed is an oligonucleotide or a pharmacologically acceptable salt thereof, wherein the oligonucleotide comprises at least one defined nucleoside structure, can bind to a human nSR100 gene and has human nSR100 expression inhibiting activity. The oligonucleotide has a length of 12 to 20 mer, and is complementary to a defined target region. Further, disclosed is an nSR100 gene expression inhibitor and a cancer therapeutic agent containing the oligonucleotide or the pharmacologically acceptable salt thereof. The cancer therapeutic agent is used for treatment of small cell lung cancer, prostate cancer, or breast cancer.

Abstract: A Brassica oleracea plant is provided having self-compatibility, or a progeny thereof, wherein the plant excludes cauliflower and Chinese kale. For example, a Brassica oleracea plant having self-compatibility is provided. Thereby, technical means that makes it possible to accomplish stable and efficient production of parental line seeds for a Brassica oleracea plant can be provided.

Abstract: The present technology is directed to compounds, compositions, and methods related to inhibition of ULK1 and treatment of cancers therefrom.

Abstract: An Fe—Co—Al alloy magnetic thin film contains, in terms of atomic ratio, 20% to 30% Co and 1.5% to 2.5% Al. The Fe—Co—Al alloy magnetic thin film has a crystallographic orientation such that the (100) plane is parallel to a substrate surface and the <100> direction is perpendicular to the substrate surface. The Fe—Co—Al alloy magnetic thin film has good magnetic properties, that is, a magnetization of 1440 emu/cc or more, a coercive force of less than 100 Oe, a damping factor of less than 0.01, and an FMR linewidth ?H at 30 GHz of less than 70 Oe.

Abstract: A tow bar fitting for towing an aircraft is disclosed. The tow bar fitting includes a mount, a pin support, and a tow pin. The mount includes an upper attachment and a lower attachment for affixing the tow bar fitting to a landing gear of the aircraft. The pin support extends from the mount away from the landing gear. The tow pin is positioned in the pin support such that a tow pin plane that horizontally bisects the tow pin is lower than a mount plane that horizontally bisects the upper attachment and the lower attachment when the aircraft is right-side-up on the ground.

Abstract: There is provided an acoustically treated landing gear door for reducing noise from a landing gear of an aircraft. The acoustically treated landing gear door includes a landing gear door for attachment to the aircraft. The landing gear door includes an acoustic treatment assembly integrated on an inner mold line of an interior side, and extending within an interior cavity of the landing gear door. The acoustic treatment assembly includes a core structure having a first side and a second side, a plurality of core cells extending between the first side and the second side, and a drainage system. The acoustic treatment assembly further includes an acoustic facesheet and a nonporous backsheet. The acoustically treated landing gear door reduces the noise from the landing gear, when the landing gear is in a deployed position, by attenuating acoustic waves emanating from the landing gear and reflected off the acoustic treatment assembly.

Abstract: A cytoplasmic male sterile Brassica rapa plant is provided having a growth ability equivalent to that of a Brassica rapa plant having a normal cytoplasm or a progeny of the cytoplasmic male sterile Brassica rapa plant. For example, it is possible to improve the deterioration of growth ability which has been observed in the conventional cytoplasmic male sterile B. rapa plants and provide a cytoplasmic male sterile Brassica rapa plant having an improved growth ability.

Abstract: The present application discloses a cabbage having resistance against downy mildew or its progeny. The present application further discloses a method for breeding downy mildew resistant cabbage, including introducing downy mildew resistance from a Brassica oleracea plant having resistance against downy mildew into desired cabbage. One embodiment of the present invention provides a novel cabbage line showing high resistance against downy mildew and having a high commercial value as cabbage, and enables breeding such cabbage.

Abstract: A tien-cha extract essence characterized by being obtained by subjecting a tien-cha extract to an activated carbon treatment, and a method for producing a fermented food product using the tien-cha extract essence provide a technique which can be replaced for a tien-cha essence obtained by subjecting a tien-cha extract to electrodialysis having various problems, has no effect on flavor while maintaining the effects of the tien-cha extract of increasing the growth ability of lactic acid bacteria and the viability or the like of bifidobacterium bacteria, has an unprecedented effect of increasing the growth ability of bifidobacterium bacteria, and facilitates production and powderization.

Abstract: Disclosed are dihydroisoxazole compounds of Formula (I) and pharmaceutically acceptable salts thereof, wherein A, E, and R1 are as defined herein. Also disclosed are compositions which comprise at least one of these dihydroisoxazole compounds, methods for inhibiting growth of mycobacterial cells as well as a method of treating mycobacterial infections by Mycobacterium tuberculosis comprising administering a therapeutically effective amount of these dihydroisoxazole compounds and/or a pharmaceutically acceptable salt thereof, or a composition comprising such compound and/or salt.

Abstract: A method is provided of producing a Lactuca plant seed including using a Megachile bee as pollination means, and providing the a Megachile bee a minor nectar plant to have preference in flower visiting, in addition to a pollen parent Lactuca plant and a seed parent Lactuca plant and to perform a crossing of a Lactuca plant using a plant species having the preference in flower visiting equivalent to or lower than that of the Lactuca plant. According to one embodiment, it is possible to produce a Lactuca hybrid plant seed more efficiently and economically than before while using a Megachile bee as pollination means.

Abstract: A cytoplasmic male sterile plant of the genus Lactuca is provided having low temperature growth ability comparable to that of a plant of the genus Lactuca with a normal cytoplasm, or a progeny thereof. For example, it is possible to alleviate a reduction in the growth ability at low temperature observed in previous CMS plants of the genus Lactuca and provide a CMS plant of the genus Lactuca having low temperature growth ability.

Abstract: A proliferation promoting effect on lactic acid bacteria during production and a viability improving effect during storage are obtained by a method for producing a lactic acid bacterium fermentation food product characterized in that when a lactic acid bacterium fermentation food product is produced by inoculating and culturing lactic acid bacteria in a medium containing a milk or a milk product as a main component, a lipase degradation product of an oil or fat is added to the medium containing a milk or a milk product as a main component before culturing lactic acid bacteria, or to a fermented liquid during or after culturing.

Abstract: The present invention is directed to pyrazol-4-yl-pyridine compounds which are allosteric modulators of the M4 muscarinic acetylcholine receptor. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which M4 muscarinic acetylcholine receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which M4 muscarinic acetylcholine receptors are involved.

Abstract: The present invention discloses oxazolidinone compounds of Formula (I): (I) and pharmaceutically acceptable salts thereof, wherein A and E, are as defined herein. The present invention also relates to compositions which comprise at least one oxazolidinone compound of the invention. The invention also provides methods for inhibiting growth of mycobacterial cells as well as a method of treating mycobacterial infections by Mycobacterium tuberculosis comprising administering a therapeutically effective amount of an oxazolidinone of the invention and/or a pharmaceutically acceptable salt thereof, or a composition comprising such compound and/or salt.